A July 2026 JCEM study found semaglutide and tirzepatide linked to greater hip bone loss, especially in people without diabetes. Here’s what GLP-1 patients need to know now.
GLP-1 Weight-Loss Drugs May Be Thinning Bone: Doctors Are Starting to Have This Conversation with Patients
by | Jul 24, 2026 | Uncategorized | 0 comments
Recent Comments